Patents by Inventor Heino Stass

Heino Stass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained-Release Preparations Of Quinolone Antibiotics
    Publication number: 20070237824
    Abstract: The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.
    Type: Application
    Filed: June 14, 2007
    Publication date: October 11, 2007
    Applicant: Bayer Healthcare Aktiengesellschaft
    Inventors: Venkata-Rangarao Kanikanti, Roland Rupp, Wolfgang Weber, Peter Deuringer, Jan-Olav Henck, Heino Stass, Takaaki Nishioka, Yoshifumi Katakawa, Chika Taniguchi, Hitoshi Ichihashi
  • METHOD OF PREPARING SUSTAINED-RELEASE PREPARATIONS OF QUINOLONE ANTIBIOTICS
    Publication number: 20070065509
    Abstract: The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.
    Type: Application
    Filed: November 16, 2006
    Publication date: March 22, 2007
    Inventors: Venkata-Rangarao Kanikanti, Roland Rupp, Wolfgang Weber, Peter Deuringer, Jan-Olav Henck, Heino Stass, Takaaki Nishioka, Yoshifumi Katakawa, Chika Taniguchi, Hitoshi Ichihashi
  • Sustained-release preparations of quinolone antibiotics and method for preparation thereof
    Publication number: 20040024018
    Abstract: The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.
    Type: Application
    Filed: May 30, 2003
    Publication date: February 5, 2004
    Inventors: Venkata-Rangarao Kanikanti, Roland Rupp, Wolfgang Weber, Peter Deuringer, Jan-Olav Henck, Heino Stass, Takaaki Nishioka, Yoshifumi Katakawa, Chika Taniguchi, Hitoshi Ichihashi
  • Medicament formulation with a controlled release of an active agent
    Patent number: 6270799
    Abstract: The invention relates to drug formulations which comprise 1-cyclopropyl-7-([S,S]-2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quino-lonecarboxylic acid and/or pharmaceutically tolerable salts thereof and/or hydrates thereof as active compound which release the active compound they contain at a defined release rate.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: August 7, 2001
    Assignee: Bayer Aktiengesellscahft
    Inventors: Hans-Martin Siefert, Patrick Bosché, Heino Stass, Stefan Kettelhoit, Tobias Laich